| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |